Hypothyroidism Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Hypothyroidism Clinical Trial Report Overview
The total number of Hypothyroidism clinical trials conducted as of December 2023 was 467. The Hypothyroidism clinical trial report includes information about the sponsor type and the prominent sponsors associated with the Hypothyroidism clinical trials. The following are some of the key highlights of the Hypothyroidism clinical trials market:
- Asia-Pacific led the Hypothyroidism clinical trials landscape with more than 60% of the clinical trials conducted as of December 2023.
- As of December 2023, most of Hypothyroidism clinical trials conducted were sponsored by institution sponsor type.
- In 2023, IBSA Institut Biochimique SA conducted the highest number of Hypothyroidism clinical trials.
The report provides a comprehensive understanding of the Hypothyroidism clinical trial scenario across regions, and countries (G7 & E7). The report covers details on the various phases, trial status, and end points status. The Hypothyroidism clinical trials analysis report also offers exhaustive information on the prominent drug names and trial counts of in-progress trials.
Key Regions | · Asia-Pacific
· North America · Europe · Middle East and Africa · South and Central America |
Key Countries | · India
· Iran · United States · China · Italy |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · IBSA Institut Biochimique SA
· E. Merck KG · Viatris Inc · Uni-Pharma SA · Teva Pharmaceutical Industries Ltd |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Hypothyroidism Clinical Trials Segmentation by Regions and Countries
The key regions conducting clinical trials for Hypothyroidism are Asia-Pacific, Europe, North America, Middle East and Africa, and South and Central America. The top 5 countries in APAC were India, China, South Korea, Japan, and Australia.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Japan had the highest proportion of hypothyroidism to hormonal disorders clinical trials as of December 2023. The majority of the clinical trials for hypothyroidism were completed.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Indonesia had the highest proportion of hypothyroidism to hormonal disorders clinical trials as of December 2023. The majority of the clinical trials accounted for the completed trial status.
Hypothyroidism Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Hypothyroidism Clinical Trials
Download a Free Sample Report
Hypothyroidism Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Hypothyroidism clinical trials are company, institution, and the government. As of December 2023, more than 50% of Hypothyroidism clinical trials conducted were sponsored by institution sponsor type, followed by company.
Hypothyroidism Clinical Trials Analysis by Sponsor Type, 2023 (%)
Buy the Full Report for More Insights into the Hypothyroidism Clinical Trials Sponsor Types
Hypothyroidism Clinical Trials - Competitive Landscape
A few of the leading sponsors for Hypothyroidism clinical trials are:
- IBSA Institut Biochimique SA
- Merck KG
- Viatris Inc
- Uni-Pharma SA
- Teva Pharmaceutical Industries Ltd
Hypothyroidism Clinical Trials Analysis by Leading Companies, 2023 (%)
Buy Full Report to Know More About the Leading Players of Hypothyroidism Clinical Trials
Segments Covered in the Report
Hypothyroidism Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Hypothyroidism Clinical Trials Country Outlook (2023)
- India
- Iran
- United States
- China
- Italy
Hypothyroidism Clinical Trials Sponsor Type Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key investment strategies.
- Helps in identifying time-saving and cost-efficient locations to conduct clinical trials.
- Provides top-level analysis of the global clinical trials market to help in identifying key business opportunities.
- Helps in understanding trial count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
E. Merck KG
Viatris Inc
Uni-Pharma SA
PRACS Institute, Ltd. (Inactive)
Teva Pharmaceutical Industries Ltd
Akrimax Pharmaceuticals LLC
Amgen Inc
Intas Pharmaceuticals Ltd
Takeda Pharmaceutical Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Hypothyroidism clinical trials in December 2023?
Asia-Pacific accounted for the highest number of Hypothyroidism clinical trials as of December 2023.
-
Which country conducted the highest number of Hypothyroidism clinical trials in December 2023?
India conducted the highest number of Hypothyroidism clinical trials as of December 2023.
-
Which sponsor type was the most prominent in the Hypothyroidism clinical trials in December 2023?
As of December 2023, most of the Hypothyroidism clinical trials conducted were sponsored by institution sponsor type.
-
Which are the leading sponsors of Hypothyroidism clinical trials?
A few of the leading sponsors of Hypothyroidism clinical trials are IBSA Institut Biochimique SA, E. Merck KG, Viatris Inc, Uni-Pharma SA, and Teva Pharmaceutical Industries Ltd, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.